From Ideas to Impact: Emerging Health Technologies in Action

1 – 2 Jun 2026 | Brussels, Belgium

Register
Register
Register

National Center for Disease Control and Public Health

Public Authority/Government

test.ncdc.ge/default.aspxTbilisi, Georgia
3 profile visits

About

National Center for Disease Control and Public Health (NCDC) is the leading national public health institution in Georgia operating under the Ministry of Health. NCDC is responsible for communicable and noncommunicable disease surveillance, prevention and control, immunization, antimicrobial resistance (AMR), health promotion, epidemiology, laboratory systems, emergency preparedness and response, and public health research.

The institution collaborates with major international organizations and research partners, including World Health Organization, Centers for Disease Control and Prevention, UNICEF, the European Union, and academic institutions. NCDC has extensive experience in implementation research, behavioral and cultural insights, health communication, digital health, cancer prevention and screening, infectious disease control, and health systems strengthening.

NCDC coordinates nationwide surveillance and public health programs and provides access to research infrastructure, laboratory networks, primary healthcare collaborations, implementation settings, and multidisciplinary expertise supporting innovation, policy translation, and real-world public health impact.

Areas of Activity

IHI Topic 1: IHI European healthcare incubator networkIHI Topic 2: An AI foundation toxicology model and framework to support waiving a second species in drug safety studiesIHI Topic 3: Decode the immuno-science of age-related mediated diseasesHORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research (RIA)HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease (RIA)HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers (RIA)HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care (RIA)HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC) (IA)HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine (RIA)HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients (RIA)HORIZON_MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatmentHORIZON_MISS-2027-02-CANCER-02 Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancersHORIZON_MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypesHORIZON_MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes researchHORIZON_MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicinesHORIZON_MISS-2027-02-CANCER-06 Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies

Representatives

Chief Specialist

National Center for Disease Control and Public Health